exhibit 10. 47 animal clinical trial agreement ( sars - cov - 2 ) this animal clinical trial agreement made and effective as september 14, 2020 ( herein the “ effective date ” ) by and between applied dna sciences, inc., a delaware corporation, with an address of 50 health sciences drive, stony brook, ny 11790 ( herein “ applied dna ” ), evvivax s. r. l., a italian limited liability company, with an address of via di castel romano 100, 00128 roma, italy ( herein “ evvivax ” and together with applied dna herein the “ sponsors ” ), and veterinary oncology services, pllc, a new york limited liability company, with an address of 69 dakota drive, hopewell junction, ny 12533, usa ( herein the “ clinical research team ” ). whereas, multiple studies have shown that felis catus ( domesticated cats ) are susceptible to infection by sars - cov - 2, the virus that causes the disease covid - 19 in humans ; whereas, the sponsors have jointly developed pcr manufactured dna - based vaccine candidates against sars - cov - 2 that have shown the production of t cell immunity and antibodies against sars - cov - 2 in pre - clinical studies ; whereas, the research program contemplated by this agreement is of mutual interest and benefit to clinical research team and to the sponsors and will potentially further the development of a dna - based vaccine against sars - cov - 2 in domesticated cats ; now, therefore, the parties hereto agree as follows : 1. statement of work. clinical research team agrees to use its reasonable efforts to perform the research program ( herein the “ research program ” ) as set forth in exhibit a. clinical research team shall not make changes to the research program without the prior written consent of sponsors. clinical research team shall ensure that staff members who are participating in the research program have been properly informed about the requirements of the research program and the rules and regulations under which the research program is to be conducted, and have the necessary qualifications, experience, authorizations and supervision to perform their assigned duties. 1. statement of work. clinical research team agrees to use its reasonable efforts to perform the research program ( herein the “ research program ” ) as set forth in exhibit a. clinical research team shall not make changes to the research program without the prior written consent of sponsors. clinical research team